Dorsey Wright & Associates Syndax Pharmaceuticals Inc Transaction History

Dorsey Wright & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$13.42 - $25.18 $18,922 - $35,503	-1,410 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$19.28 - $24.59 $15,616 - $19,917	810 Added 135.0%	1,410 $31.5 Million
Q4 2020 Jan 28, 2021	BUY	$15.1 - $26.44 $9,060 - $15,864	600 New	600 $13,000
Q2 2020 Jul 23, 2020	SELL	$8.94 - $20.98 $7,178 - $16,846	-803 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$6.65 - $12.03 $5,339 - $9,660	803 New	803 $9,000

Q4 2019 Jan 31, 2020	SELL	$5.43 - $9.22 $5,782 - $9,819	-1,065 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$7.47 - $10.76 $7,955 - $11,459	1,065 New	1,065 $8,000

195

90M

353K

207K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.18B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.